Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

Wayne A. Border(University of Utah), Nancy A. Noble(University of Utah), Tatsuo Yamamoto(University of Utah), John R. Harper, Yu Yamaguchi(National Foundation for Cancer Research), Michael D. Pierschbacher(Sanford Burnham Prebys Medical Discovery Institute), Erkki Ruoslahti(Sanford Burnham Prebys Medical Discovery Institute)

Nature

November 1, 1992

10.1038/360361a0

Cited by 976

Abstract

Related Papers

Handbook of Experimental Pharmacology.

J. W. Meakin|Archives of Internal Medicine|1971|2k

Negative regulation of transforming growth factor-β by the proteoglycan decorin

Yu Yamaguchi, David Mann, Erkki Ruoslahti|Nature|1990|1.5k

Transforming growth factor-beta in disease: the dark side of tissue repair.

Wayne A. Border, Erkki Ruoslahti|Journal of Clinical Investigation|1992|1.1k

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

Wayne A. Border, Seiya Okuda, Lucia R. Languino et al.|Nature|1990|1k

Use of Single Voided Urine Samples to Estimate Quantitative Proteinuria

Jay M. Ginsberg, Bruce S. Chang, Richard A. Matarese et al.|New England Journal of Medicine|1983|762